Back to Agenda
Panel Detail

Time=Lives Talk: Research, Collaboration, and Remission

Wednesday, July 12, 2017
3:45 PM - 4:00 PM
Great Room
David Fajgenbaum entered medical school on a quest to cure cancer, the disease that claimed his mother's life. He didn't know that his medical training would ultimately serve a mission to cure himself. At 25, Fajgenbaum was diagnosed with idiopathic multicentric Castleman disease (iMCD), a disease that has brought him to the brink of death five times. Between relapses, Fajgenbaum has become unrelentingly dedicated to curing iMCD by establishing the Castleman Disease Collaborative Network and acting as his own research and test subject for potential treatments. He is currently in his longest remission but understands his time is precious and is driven to end the disease for his future and for all iMCD patients.


David Fajgenbaum

Associate Director, Patient Impact, Orphan Disease Center, University of Pennsylvania; Co-Founder & Executive Director, Castleman Disease Collaborative Network